Welcome to LookChem.com Sign In|Join Free
  • or
(1H-Pyrrolo[2,3-c]pyridin-2-yl)MethanaMine, a heterocyclic amine with the molecular formula C8H7N3, is a chemical compound featuring a pyrrolopyridine structure. It is frequently utilized in pharmaceutical research as a key building block for the synthesis of potential drug candidates. (1H-Pyrrolo[2,3-c]pyridin-2-yl)MethanaMine's distinctive structural attributes and functional groups render it a valuable intermediate for the development of innovative medications, especially for the treatment of conditions like cancer, inflammation, and neurological disorders. Moreover, it may also hold promise in other sectors such as materials science and organic electronics. Given its intricate structure and potential reactivity, meticulous handling and comprehensive testing are imperative to guarantee its safe and efficacious application across various domains.

867140-61-2

Post Buying Request

867140-61-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

867140-61-2 Usage

Uses

Used in Pharmaceutical Research:
(1H-Pyrrolo[2,3-c]pyridin-2-yl)MethanaMine is used as a building block for the synthesis of potential drug candidates due to its unique pyrrolopyridine structure and functional groups, which contribute to the development of new medications for the treatment of various diseases.
Used in the Treatment of Cancer:
In the field of oncology, (1H-Pyrrolo[2,3-c]pyridin-2-yl)MethanaMine is used as a precursor in the development of anticancer drugs, leveraging its structural properties to target and combat cancer cells.
Used in the Treatment of Inflammatory Diseases:
(1H-Pyrrolo[2,3-c]pyridin-2-yl)MethanaMine is utilized as a component in the creation of anti-inflammatory agents, potentially mitigating the effects of inflammation through its interaction with relevant biological targets.
Used in Neurological Disorder Treatment:
Within neurology, (1H-Pyrrolo[2,3-c]pyridin-2-yl)MethanaMine is employed as a constituent in the formulation of drugs aimed at addressing neurological disorders, potentially improving patient outcomes through its specific molecular interactions.
Used in Materials Science:
In materials science, (1H-Pyrrolo[2,3-c]pyridin-2-yl)MethanaMine may be used as a component in the development of novel materials, capitalizing on its chemical properties to enhance material characteristics.
Used in Organic Electronics:
(1H-Pyrrolo[2,3-c]pyridin-2-yl)MethanaMine is also used in the field of organic electronics, where its electronic properties could be harnessed for the advancement of organic electronic devices.

Check Digit Verification of cas no

The CAS Registry Mumber 867140-61-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,7,1,4 and 0 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 867140-61:
(8*8)+(7*6)+(6*7)+(5*1)+(4*4)+(3*0)+(2*6)+(1*1)=182
182 % 10 = 2
So 867140-61-2 is a valid CAS Registry Number.
InChI:InChI=1/C8H9N3/c9-4-7-3-6-1-2-10-5-8(6)11-7/h1-3,5,11H,4,9H2

867140-61-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 1H-pyrrolo[2,3-c]pyridin-2-ylmethanamine

1.2 Other means of identification

Product number -
Other names (1H-pyrrolo[2,3-c]pyridin-2-yl)methanamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:867140-61-2 SDS

867140-61-2Downstream Products

867140-61-2Relevant academic research and scientific papers

LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF

-

, (2018/03/28)

Described herein are compounds that are LOXL2 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with LOXL2 activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 867140-61-2